-+ 0.00%
-+ 0.00%
-+ 0.00%

enVVeno Medical Board Approves Reverse Stock Split Of Common Shares At Ratio Of 1 For 35

Benzinga·01/15/2026 13:02:21
Listen to the news

enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the "Company"), today announced that the Company's Board of Directors has approved a reverse stock split of its shares of common stock at a ratio of 1 for 35 (the "Reverse Stock Split"). The Reverse Stock Split will become effective at 12:01 a.m. Eastern time on January 20, 2026 and the Company's common stock will open for trading on The Nasdaq Capital Market on a post-split basis on January 20, 2026 under the Company's existing trading symbol "NVNO". At such time, the Company's common stock will also commence trading under a new CUSIP number 29415J205.